While IBD-KID2 has previously been shown to have validity and reliability, external validity (generalizability), has not yet been established outside the center where it was developed, thereby limiting the extent to which the original findings can be extrapolated to other IBD cohorts in other centers and countries. The gene discussed is ZNF354B; the disease is inflammatory bowel disease.